Insights into the use of Ketamine for Depression

Last month the F.D.A. approved the use of esketamine as an antidepressant for individuals that have tried at least two other treatments for depression. Esketamine is the first ketamine-derived medicine, meaning that it is molecularly part of ketamine. At NMHIC, we have been aware of the use of ketamine for depression, but for a majority of the population this is …

Event Blog: Mimi McFaul at the Healthier Rural West Summit

A few weeks ago, our deputy director, Mimi McFaul attended and spoke at the Healthier Rural West Summit in Salt Lake City – a meeting of the minds seeking to take on the challenges presented in meeting the public health needs of the West’s rural communities. Over 400 people representing rural healthcare providers, leaders in technology, business and government gathered …

Mental Health has a place in every Profession

One in four Americans will experience a mental illness in a given year. Only half, however, receive treatment. Many suffer in silence due to stigma and lack of support or access to care. Even if every person in need sought help, it is unlikely we would see a reduction in the burden of mental illness on a population level. There …

Event Blog: NMHIC at the State Innovation Model Collaborative Learning Session

Sarah Beary and Sam Hubley recently spoke at the State Innovation Model (SIM) Collaborative Learning Session in Broomfield, CO. The SIM is a state-wide grant from the Center for Medicare and Medicaid Innovation that focuses on increasing access for all Coloradoans to integrated behavioral health and primary care services. NMHIC received an invitation to present at the Collaborative Learning Session …